No. 84-2, June 2022
Index
- Balance and Standardization: Implications for Competition and Antitrust Analysis
- The Neglected Concern of Firm Size in Pharmaceutical Mergers
- Collusion in Plain Sight: Firms' Use of Public Announcements to Restrain Competition
- Replacing the Structural Presumption
- The Role of Efficiency Evidence in Price-Fixing Litigation
- Editors' Note
- The Illinois Brick Damages Edifice: Demolition or Deconstruction?
- Unintended Consequences of Repealing the Direct Purchaser Rule
- Let's Talk About Consumers: Competition Law Compensation for Indirect Purchasers' Losses-A United Kingdom Perspective